Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026)
Prokidney's (PROK) quarterly Other Non-Current Liabilities came in at $1.1 million in Q2 2026, up 18.94% year-over-year from $903000.0 in Q2 2025, and little changed quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Prokidney (PROK) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Prokidney (PROK) has reported Other Non-Current Liabilities for 5 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 18.94% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 18.94% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 43.58% from the prior year.
- Other Non-Current Liabilities was $1.1 million for Q2 2026 at Prokidney, roughly flat from $1.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $1.1 million in Q4 2025 and troughed at $278000.0 in Q4 2022.
- A 5-year average of $694000.0 and a median of $658000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities surged 104.32% in 2023 and rose 14.98% in 2024, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $278000.0 in 2022, then jumped by 104.32% to $568000.0 in 2023, then soared by 31.69% to $748000.0 in 2024, then surged by 43.58% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.1 million (Q2 2026), $1.1 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 903,000.00 |
| Mar 31, 2025 | 764,000.00 |
| Dec 31, 2024 | 748,000.00 |
| Sep 30, 2024 | 772,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 568,000.00 |
| Dec 31, 2023 | 568,000.00 |
| Sep 30, 2023 | 522,000.00 |
| Jun 30, 2023 | 494,000.00 |
| Mar 31, 2023 | 426,000.00 |
| Dec 31, 2022 | 278,000.00 |
| Sep 30, 2022 | 309,000.00 |